Healthcare · Technology · Industry · Markets · Washington, D.C.

Where science meets
market intelligence.

Institutional-quality research at the intersection of healthcare science, policy, and markets — built by the next generation of investors.

FDA Catalyst Tracking Healthcare M&A Intelligence Policy & Regulatory Analysis Small-Cap Biotech Research Tech & Consumer Sector Coverage Precious Metals & Energy CMS Reimbursement Signals Proprietary Trade Documentation Washington Policy Intelligence FDA Catalyst Tracking Healthcare M&A Intelligence Policy & Regulatory Analysis Small-Cap Biotech Research Tech & Consumer Sector Coverage Precious Metals & Energy CMS Reimbursement Signals Proprietary Trade Documentation Washington Policy Intelligence
Our Focus

Two verticals. Two core sectors.

Research & Publications

Memos across healthcare, biotech, tech, consumer, energy, and precious metals — with scientific and policy depth generalists lack.

View publications

M&A Advisory

Deal sourcing and seller prep for healthcare and industry rollups. CIM building, outreach, and negotiation support.

Learn more
Our Philosophy

An edge built on
what others lack.

Three capabilities that most analysts have separately but rarely together — combined into a single research and advisory operation.

Research and analysis
01
Scientific literacy

We read trial data, assess drug mechanisms, and understand FDA pathways — not just headlines. Our research starts where most analysts stop.

02
Policy intelligence

Policy moves deal flow and valuations. We track CMS changes, drug pricing, antitrust enforcement, and regulatory shifts — translating them to market implications before they're priced in.

03
Deal pattern recognition

Hands-on PE rollup experience informs how we evaluate M&A targets, valuations, and sector consolidation dynamics across healthcare and general industry.

Ready for intelligence
that actually moves?

Whether you're an investor, operator, or analyst — we deliver the context you need.

Research & Publications

Investment memos built
on genuine depth.

Biotech & Healthcare — FDA catalysts, clinical readouts, CMS policy, M&A targets.
General Industry — tech, consumer, energy, and precious metals, viewed through a policy and catalyst lens.

Subscribe on Substack
General Industry

The Merger Nobody Outside Finance Is Watching (But Should Be)

Between every WSJ article, Bloomberg newscast, and X post mentioning SpaceX, AI, or IPOs, public investors can easily glaze over what would otherwise be sensational news in a steadier market. Two of the largest U.S. utility companies are merging, and the center of gravity is right in D.C.’s backyard: Ashburn, Virginia. The catalyst? AI, of course.

June 2026Read on Substack

Get every memo in your inbox.

Subscribe on Substack for weekly research across healthcare and general industry.

Subscribe free
M&A Advisory

From first outreach to
closing the deal.

Boutique M&A advisory for healthcare and general industry operators. We source targets, run acquisition outreach, and prepare business owners for a transaction — building their CIM and positioning them to negotiate from strength.

What We Do

Two sides of every deal.

Deal Sourcing & Acquisition Outreach

We source targets for PE operators and rollup platforms in healthcare and general industry. Outreach is direct and relationship-driven, focused on off-market opportunities not yet shopped to brokers.

Target identification based on buyer criteria
Cold and warm outreach to business owners
Initial screening and qualification
Off-market deal flow generation

CIM Preparation & Seller Advisory

We work with owners considering a sale — building the CIM, clarifying valuation, and preparing them to negotiate with buyers from an informed position.

CIM drafting and financial narrative
Business valuation context and benchmarking
Negotiation preparation and deal structure
Financial clean-up and presentation

Sector Focus: Healthcare Services

Active coverage of dental, veterinary, behavioral health, med spa, physical therapy, and home health — sectors where our scientific and regulatory knowledge creates real sourcing edge.

Dental & DSO rollup support
Behavioral health & mental health platforms
Med spa, aesthetics, and wellness
Home health & care management

General Industry Advisory

Deal sourcing for blue-collar service rollups — HVAC, landscaping, plumbing, and cleaning — where PE consolidation is active and our process applies directly.

Blue-collar service business sourcing
Owner outreach and relationship building
Business readiness assessment
Transaction preparation support
Our Process

How we work.

01
Define Criteria

Define target profile: sector, size, geography, margin, and deal structure.

02
Source & Outreach

Direct cold and warm outreach. Off-market focus to avoid broker competition and premium.

03
Qualify & Prepare

Screen against criteria. Build the CIM and financial narrative before any buyer conversation.

04
Support to Close

Advise through LOI, diligence, and negotiation. Help sellers defend valuation and understand deal structure.

Get Started

Whether you are a buyer
or a seller — let us talk.

Reach out with a brief description of what you are looking to accomplish and we will respond within 48 hours.

About Alvendale

Healthcare-first intelligence,
built for the long game.

Lab
Based in Washington, D.C.
2026
Founded
100%
Independent
2
Verticals
Our Story

The edge others do not have.

Most healthcare analysts are either scientists who cannot read a model, or modelers who cannot read a clinical trial. Alvendale sits at the intersection of both.

Alvendale combines scientific literacy, DC policy knowledge, and deal pattern recognition into research and advisory that generalist firms cannot replicate.

Two sectors: Biotech & Healthcare, and General Industry. Built for the long game — a five-year arc toward a credible, compounding firm.

Our Values

What we stand for.

No conflicts of interest

All holdings disclosed on written research. Analysis driven by rigor, not positioning.

Auditable everything

Every trade documented before entry. Every research call written before the outcome is known.

Long-game thinking

Every decision evaluated against whether it compounds toward a credible firm in five years.

Get in Touch

Let's start a conversation.

Whether you're a reader, a potential advisory client, or just curious — reach out and we'll respond within 48 hours.

Washington, D.C.